Atlas Trials

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Clinical trial NCT02607449 · COMPLETED

Trial details

NCT number
NCT02607449
Sponsor
Scientific Center for Anti-infectious Drugs, Kazakhstan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tuberculosis, MDR
Start date
2013-12-01
Primary completion
2020-08-01
Enrollment
344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.